May 13, 2022: The Centers for Disease Control and Prevention listed six Connecticut Counties in the High/Orange category as part of its COVID-19 Community Levels Map. Only Fairfield and New London Counties are listed in the Medium/Yellow category. Residents in these counties should wear a mask indoors in public; stay up to date with COVID-19 vaccines and get tested if they have symptoms. Additional precautions may be needed for residents who are at high risk for severe illness. Visit the CDC COVID-19 Community Levels Map for updates.

Asthma Program

 
MISSION STATEMENT
 
The mission of the Connecticut Asthma Program is to reduce asthma associated morbidity and mortality, decrease asthma disparities and, support Connecticut residents living with asthma in achieving asthma control and improving their quality of life.

The Asthma Program is part of the Chronic Diseases Unit within the Community, Family Health, and Prevention Section at the Connecticut Department of Public Health. Under a cooperative agreement with the U.S. Centers for Disease Control and Prevention (CDC), the asthma program is committed to reducing asthma disparities and improving access to comprehensive asthma control management.

THE CONNECTICUT ASTHMA PROGRAM’S GOALS
  • Partnering with health care and community systems to provide culturally appropriate and effective delivery of coordinated asthma services to communities most affected by asthma
  • Advancing the integration of Community Health Workers to address social determinants of health and barriers to asthma management and facilitate access health care services.
  • Providing community asthma education and expand access to CT’s asthma home visiting program.
  • Promote guidelines-based asthma care to health professionals in community health centers and schools.
  • Reducing/eliminating exposure to indoor and outdoor environmental asthma triggers. 
  • Support policies to improve access to affordable and quality housing, advancing the adoption of and assist in advancing the adoption of policies to improve indoor and outdoor air. 
  • Promoting CDC’s comprehensive approach to asthma management through its EXHALE strategic framework.
  • Using datasets to identify and monitor the impact of asthma strategies on groups of the population disproportionately affected by asthma.
  • Using CDC’s evaluation approach to determine the programmatic activities’ effectiveness, and to implement recommendations for improvement.
ASTHMA AND COVID-19 People who have moderate to severe asthma may be at higher risk of severe illness from the coronavirus disease (COVID-19). For more information about COVID-19, please click here for the CT COVID-19 Response website.

BRIEF OVERVIEW: CT ASTHMA Asthma is a chronic disease that affects 25 million of children and adults nationwide or 7.8% of the US population (see national asthma data).  Compared to other states, Connecticut was among the top 12 states with the highest percentage of adults with asthma in 2019 (see adult asthma data across states).  Through its asthma surveillance activities, the Connecticut Asthma Program (CAP) can identify at-risk populations and monitor trends in asthma rates across the state.  Click here for more details on CT Asthma Statistics.

Connecticut Asthma Statistics
:
  • In 2019, 71,900 (10.6%) children and 298,000 (10.5%) adults had asthma.
  • In 2019, the state’s asthma hospitalization was 6.4 per 10,000 populations.
  • In 2019, the state’s emergency department (ED) visit was 54.2 per 10,000 populations In 2019, Connecticut incurred $105,620,169 million acute care charges due to asthma as a primary diagnosis. Of that amount, $55.3 million were for hospitalizations and $50.3 million were for emergency department (ED) visits.
  • Of the $105.6 million, $74 million (73%) were charged to public funds (Medicaid or Medicare).
asthma stats
 
In CT, it has been found that children, women, residents of Hispanic and non-Hispanic black communities, are disproportionately affected by asthma. Noteworthy, the state’s five largest cities (Bridgeport, Hartford, New Haven, Stamford, and Waterbury) account for 17.8% of Connecticut’s total population, yet they account for nearly half (43%) of the $105.6 million of asthma acute care charges. For more details, see surveillance page
 

Putting on AIRS

 

 
 
 
 
 
 

 

 

 The Connecticut Asthma Program can be reached at 860-509-8251